The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Obstetric Care Consensus No. 7: Placenta Accreta Spectrum
Abstract
Placenta accreta spectrum, formerly known as morbidly adherent placenta, refers to the range of pathologic adherence of the placenta, including placenta increta, placenta percreta, and placenta accreta. The most favored hypothesis regarding the etiology of placenta accreta spectrum is that a defect of the endometrial–myometrial interface leads to a failure of normal decidualization in the area of a uterine scar, which allows abnormally deep placental anchoring villi and trophoblast infiltration. Maternal morbidity and mortality can occur because of severe and sometimes life-threatening hemorrhage, which often requires blood transfusion. Although ultrasound evaluation is important, the absence of ultrasound findings does not preclude a diagnosis of placenta accreta spectrum; thus, clinical risk factors remain equally important as predictors of placenta accreta spectrum by ultrasound findings. There are several risk factors for placenta accreta spectrum. The most common is a previous cesarean delivery, with the incidence of placenta accreta spectrum increasing with the number of prior cesarean deliveries. Antenatal diagnosis of placenta accreta spectrum is highly desirable because outcomes are optimized when delivery occurs at a level III or IV maternal care facility before the onset of labor or bleeding and with avoidance of placental disruption. The most generally accepted approach to placenta accreta spectrum is cesarean hysterectomy with the placenta left in situ after delivery of the fetus (attempts at placental removal are associated with significant risk of hemorrhage). Optimal management involves a standardized approach with a comprehensive multidisciplinary care team accustomed to management of placenta accreta spectrum. In addition, established infrastructure and strong nursing leadership accustomed to managing high-level postpartum hemorrhage should be in place, and access to a blood bank capable of employing massive transfusion protocols should help guide decisions about delivery location.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maternal Morbidity Associated With Multiple Repeat Cesarean Deliveries
Silver, R. M., Landon, M. B., Rouse, D. J., Leveno, K. J., Spong, C. Y., Thom, E. A., Moawad, A. H., Caritis, S. N., Harper, M., Wapner, R. J., et al. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000219750.79480.84 · Cited by 1,909
Shakur, H., Roberts, I., Fawole, B., Chaudhri, R., El-Sheikh, M., Akintan, A., Qureshi, Z., Kidanto, H., Vwalika, B., Abdulkadir, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30638-4 · Cited by 1,469
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Abnormal placentation: Twenty-year analysis
Wu, S., Kocherginsky, M., & Hibbard, J. U. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.12.074 · Cited by 1,331
Clinical risk factors for placenta previa–placenta accreta
Miller, D. A., Chollet, J. A., & Goodwin, T. M. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70463-0 · Cited by 1,106
Jauniaux, E., Collins, S., & Burton, G. J. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.05.067 · Cited by 775
The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage
CHARBIT, B., MANDELBROT, L., SAMAIN, E., BARON, G., HADDAOUI, B., KEITA, H., SIBONY, O., MAHIEU‐CAPUTO, D., HURTAUD‐ROUX, M. F., HUISSE, M. G., et al. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02297.x · Cited by 762
Optimal management strategies for placenta accreta
Eller, A., Porter, T., Soisson, P., & Silver, R. (2009) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.02037.x · Cited by 578
Impact of multiple cesarean deliveries on maternal morbidity: a systematic review
Marshall, N. E., Fu, R., & Guise, J.-M. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.06.035 · Cited by 565
Cited by
Hecht, J. L., Baergen, R., Ernst, L. M., Katzman, P. J., Jacques, S. M., Jauniaux, E., Khong, T. Y., Metlay, L. A., Poder, L., Qureshi, F., et al. (2020) · Modern Pathology · doi:10.1038/s41379-020-0569-1 · Cited by 263
Maternal morbidity and mortality due to placenta accreta spectrum disorders
Fonseca, A., & Ayres de Campos, D. (2021) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2020.07.011 · Cited by 102
Einerson, B. D., Gilner, J. B., & Zuckerwise, L. C. (2023) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000005229 · Cited by 100
Up-regulated cytotrophoblast DOCK4 contributes to over-invasion in placenta accreta spectrum
McNally, L., Zhou, Y., Robinson, J. F., Zhao, G., Chen, L.-M., Chen, H., Kim, M. Y., Kapidzic, M., Gormley, M., Hannibal, R., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920776117 · Cited by 41
Multidisciplinary Teams in the Management of Placenta Accreta Spectrum Disorders
Einerson, B. D., & Silver, R. M. (2019) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-019-00264-x · Cited by 13
Metadata
- Venue
- Obstetrics & Gynecology
- Published
- 2018-12
- Volume
- 132
- Issue
- 6
- Pages
- e259-e275
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W3046648536
- Cited by
- 523
- References
- 99
- FWCI
- 32.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Obstetric Care Consensus No. 7: Placenta Accreta Spectrum. https://app.cochat.ai/papers/10.1097/aog.0000000000002983
- The paper
- Obstetric Care Consensus No. 7: Placenta Accreta Spectrum. (2018). Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000002983
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.